Latest White Papers

Healthcare delivery and reimbursement models have undergone a paradigm shift; specifically, patient financial liability has significantly affected clinical laboratories and pathology groups, changing the way our businesses operate. In order to profitably provide care, it has been crucial for labs to modernize their collection practices—yet many struggle to do so.

Breakthrough methods in blood collection technology have the ability to expedite your lab’s move to patient-centered care, as well as answer the challenges of changing remote patient requirements. The Dark Report is pleased to offer this FREE White Paper, an ideal resource for those interested in new microsampling technology—what it is, how it works, and how it can transform your lab.

Personalized and predictive medicine are rapidly becoming a reality. As a result, your clinical diagnostic laboratory’s need for a laboratory information management system (LIMS) designed to accommodate personalized medicine’s informatics integration and workflow challenges has become vital. The Dark Report is pleased to offer this FREE White Paper, providing a detailed discussion on how you can unlock the potential of next generation sequencing (NGS) technology in your lab, and the benefits and contributions it can make to add clinical value and improve patient care.

The laboratory business continues to face consolidation and margin pressure, with far fewer independent labs now than just a decade ago. A laboratory’s financial success and valuation is all about top line revenue, profitability, and minimizing risk— elements that can be positively impacted by state-of-the-art revenue cycle management. Oversight of the entire revenue cycle, by conducting a constant and consistent analysis of the front-to-back end revenue processes through specific tools and workflows, can maximize the efficiency and adaptability of all of the components of the revenue cycle process to net the greatest return.

The performance capability of your laboratory’s LIS goes way beyond its ability to participate in these new value-based care initiatives—the right LIS is critical to your practice to ensure success and increased revenue.

The Dark Report is pleased to offer this FREE White Paper, providing an enlightening overview of pharmacogenomic testing and how PGx fits into current healthcare goals, a discussion of the obstacles healthcare providers, institutions and clinical diagnostic laboratories face in entering the pharmacogenomic testing market, and examples of how a cloud-based, Software-as-a-Service platform can help healthcare providers overcome those obstacles.

Latest E-Briefings

SIDM estimates approximately one in 10 patients with serious medical conditions are initially misdiagnosed, a problem that can be addressed if the right medical laboratory test is ordered at the right time for individual patients Clinical laboratory leaders know that...

Medical fraudsters are targeting Medicare recipients with schemes to persuade them to agree to genetic tests advertised as informing them if they are predisposed to specific chronic diseases or cancer Medicare scams involving orders for unnecessary, expensive testing...

Genetic data captured by this new technology could lead to a new understanding of how different types of cells exchange information and would be a boon to anatomic pathology research worldwide What if it were possible to map the interior of cells and view their...

As hospitals are forced to innovate, anatomic pathologists and medical laboratories will need to adapt to new healthcare delivery locations and billing systems As new challenges threaten the survival of many hospitals worldwide, medical laboratories may be...

First used to track cryptocurrencies such as Bitcoin, blockchain is finding its way into tracking and quality control systems in healthcare, including clinical laboratories and big pharma Four companies were selected by the US Food and Drug Administration (FDA) to...

Clinical laboratories and microbiologists will want to be on the alert for this deadly infectious agent that has killed patients through blood infections Healthcare continues to struggle with the issue of how much to disclose to the public when new and deadly...

Scientists worldwide engaged in research to develop a biomarker for dementia are predicting success, though some say additional research will be needed Could a blood test for Alzheimer’s disease soon be on clinical laboratory test menus nationwide? Perhaps so. A...

Though the field of oncology has some AI-driven tools, overall, physicians report the reality isn’t living up to the hype Artificial intelligence (AI) has been heavily touted as the next big thing in healthcare for nearly a decade. Much ink has been devoted to the...